Developer docs
API playgroundTry for free, no card

Search company profiles

Hudson River Biotechnology

Full company profile

uuid0002ww7

Namestring
Hudson River Biotechnology
Legal namestring
Hudson River Biotechnology
Company typeenum
Private
Founded yearint
2021
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersWageningen, Netherlands
HQ citystring
Wageningen
HQ countrystring
Netherlands
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
CRISPR genome editing, plant biotechnology, crop improvement services, DNA-free gene editing, agricultural biotechnology
Industry1 code
PRIMARYAFAGAIAG
Biotechnology & Gene-Edited Trait Development
Agriculture & Food Production/Crop Farming/Seed Production & Plant Breeding (Seed Multiplication, Hybrid Seed, Certified Seed)
Product category
Plant Biotechnology / Agricultural Genome Editing Services
Social media profiles1 record
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model2 records
1CRISPR Genome Editing Services
TypeLicensing Royalties
Description

The company provides CRISPR-based genome editing services to agricultural producers, enabling crop resilience and yield improvement through their proprietary BioMaas platform. Revenue is likely generated through service contracts and technology licensing arrangements with biotech and agricultural companies.

agfundernews.com
2Agrochemical Development
TypeLicensing Royalties
Description

Hudson River Biotechnology is expanding into agrochemicals using nanotech delivery platforms, which may represent an additional revenue stream through product sales or licensing.

agfundernews.com
Marketing channels3 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Personnel, Technology or R&D, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Hudson River Biotechnology provides a DNA-free CRISPR-based genome editing service for crop plants through its proprietary BioMaas platform. The platform uses protoplast-based delivery to edit plant genomes without introducing foreign DNA, supporting multi-trait targeting and scalable automation. Products are delivered to crop producers and agricultural biotechnology partners in a 12-18 month timeline.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Products completed in 12-18 months once BioMaas is implemented
Product overview1 text field

Hudson River Biotechnology offers a single unified platform called BioMaas, which provides DNA-free CRISPR-based genome editing services for crops. The platform enables producers to boost crop resilience and yield through protoplast-based gene editing. Key features include DNA-free editing (free of foreign DNA, crop and CRISPR-enzyme agnostic), multi-trait targeting (optimizing multiple embedded and desired traits in one crop), scalability through automation, and efficiency with 12-18 month product completion timelines.

Product and service1 record
1BioMaas Platform
Scale indicator2 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Pairwise is a US-based agricultural gene-editing company using CRISPR/Cas tools to develop improved varieties of fruits, vegetables, and row crops. It directly competes with HRB in delivering CRISPR-enabled trait improvements to seed and produce companies via a B2B partnering/licensing model.

TypeDirect peer
Description

Tropic Biosciences is a UK-based agricultural biotech using CRISPR-based gene editing for tropical crops (banana, coffee) and a GEiGS technology platform. It is closely comparable to HRB in deploying novel CRISPR methodologies to commercial crop improvement via partnerships.

TypeDirect peer
Description

Cibus is a US-based agricultural technology company that develops gene-edited traits in crops using its RTDS (Rapid Trait Development System) platform. It is a direct peer to HRB in commercializing non-transgenic gene edits for major row crops via licensing to seed companies.

TypeDirect peer
Description

Inari is a US-based seed-design company that combines AI with multiplex gene editing to develop high-performance seeds. It is comparable to HRB in using next-generation breeding and editing tools to deliver multi-trait seed products to row-crop partners.

TypeDirect peer
Description

Benson Hill is a US-based crop-improvement company combining genomics, AI, and breeding to develop higher-yielding, more nutritious crops. It overlaps with HRB in serving crop producers with technology-enabled seed solutions, though with a heavier food/ingredient commercial angle.

TypeBroad incumbent
Description

KeyGene is a Dutch plant-genomics company based in Wageningen (the same cluster as HRB) that provides molecular breeding, trait discovery, and genomic services to global seed companies. It is a comparable ag-biotech services peer with overlapping customer base and technology scope.

TypeBroad incumbent
Description

Bayer Crop Science operates one of the largest in-house agricultural biotech pipelines, including CRISPR-based trait development, as part of its broader seeds-and-traits portfolio. It competes with HRB by integrating similar technologies into a much larger commercial platform.

8Corteva Agriscience
TypeBroad incumbent
Description

Corteva is a major agricultural input company with significant internal gene-editing capabilities (including its own CRISPR program with Broad Institute license). It is a broad incumbent that competes for the same seed-company customer wallet as HRB, but at vastly larger scale.

TypeBroad incumbent
Description

Syngenta is a global agrochemical and seed company with active gene-editing and trait-discovery programs. It is a broad incumbent competitor that could partner with or compete against HRB depending on its internal capability roadmap.

TypeEmerging player
Description

Caribou Biosciences is a CRISPR platform company with applications spanning human therapeutics and agricultural biology. It is an emerging player with partial overlap — its underlying CRISPR technology platforms are conceptually adjacent to HRB's BioMaas, though its primary commercial focus is biomedical.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment2 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles2 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds3 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors3 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Hudson River Biotechnology

Plant Biotechnology / Agricultural Genome Editing Serviceshudsonriverbiotechnology.com

Hudson River Biotechnology firmographics

Firmographics
Name
Hudson River Biotechnology
Legal name
Hudson River Biotechnology
Website
https://hudsonriverbiotechnology.com
Company type
Private
Founded year
2021
Operating status
Operating
Headcount range
11–50 employees
Ownership category
akta.pro rank

Hudson River Biotechnology industry classification

Industry
Product category
Plant Biotechnology / Agricultural Genome Editing Services
akta.pro industry
PRIMARYAFAGAIAG
Biotechnology & Gene-Edited Trait Development
Agriculture & Food Production/Crop Farming/Seed Production & Plant Breeding (Seed Multiplication, Hybrid Seed, Certified Seed)

Keywords

  • CRISPR genome editing
  • Plant biotechnology
  • Crop improvement services
  • DNA-free gene editing
  • Agricultural biotechnology

Where Hudson River Biotechnology is headquartered

Location

Headquarters

HQ city
Wageningen
HQ country
Netherlands
HQ region
Europe

Offices1 record

Markets served

Hudson River Biotechnology business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Marketing or Sales

Revenue model

  1. CRISPR Genome Editing Services: The company provides CRISPR-based genome editing services to agricultural producers, enabling crop resilience and yield improvement through their proprietary BioMaas platform. Revenue is likely generated through service contracts and technology licensing arrangements with biotech and agricultural companies.
  2. Agrochemical Development: Hudson River Biotechnology is expanding into agrochemicals using nanotech delivery platforms, which may represent an additional revenue stream through product sales or licensing.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Hudson River Biotechnology product offering

Product offering

Core offering

Hudson River Biotechnology provides a DNA-free CRISPR-based genome editing service for crop plants through its proprietary BioMaas platform. The platform uses protoplast-based delivery to edit plant genomes without introducing foreign DNA, supporting multi-trait targeting and scalable automation. Products are delivered to crop producers and agricultural biotechnology partners in a 12-18 month timeline.

Product overview

Hudson River Biotechnology offers a single unified platform called BioMaas, which provides DNA-free CRISPR-based genome editing services for crops. The platform enables producers to boost crop resilience and yield through protoplast-based gene editing. Key features include DNA-free editing (free of foreign DNA, crop and CRISPR-enzyme agnostic), multi-trait targeting (optimizing multiple embedded and desired traits in one crop), scalability through automation, and efficiency with 12-18 month product completion timelines.

Differentiator

Problem solved

Functional benefit

Products and services

  • BioMaas Platform

Quantifiable outcome

  • Products completed in 12-18 months once BioMaas is implemented

Companies that use Hudson River Biotechnology

Customer profile

Segments2 records

Ideal customer profiles1 record

Hudson River Biotechnology technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Hudson River Biotechnology partnerships and signals

Strategic signal

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Hudson River Biotechnology competitors and assessment

Company assessment

Direct peers

  • Pairwise: Pairwise is a US-based agricultural gene-editing company using CRISPR/Cas tools to develop improved varieties of fruits, vegetables, and row crops. It directly competes with HRB in delivering CRISPR-enabled trait improvements to seed and produce companies via a B2B partnering/licensing model.
  • Tropic Biosciences: Tropic Biosciences is a UK-based agricultural biotech using CRISPR-based gene editing for tropical crops (banana, coffee) and a GEiGS technology platform. It is closely comparable to HRB in deploying novel CRISPR methodologies to commercial crop improvement via partnerships.
  • Cibus: Cibus is a US-based agricultural technology company that develops gene-edited traits in crops using its RTDS (Rapid Trait Development System) platform. It is a direct peer to HRB in commercializing non-transgenic gene edits for major row crops via licensing to seed companies.
  • Inari Agriculture: Inari is a US-based seed-design company that combines AI with multiplex gene editing to develop high-performance seeds. It is comparable to HRB in using next-generation breeding and editing tools to deliver multi-trait seed products to row-crop partners.
  • Benson Hill: Benson Hill is a US-based crop-improvement company combining genomics, AI, and breeding to develop higher-yielding, more nutritious crops. It overlaps with HRB in serving crop producers with technology-enabled seed solutions, though with a heavier food/ingredient commercial angle.

Broad incumbents

  • KeyGene: KeyGene is a Dutch plant-genomics company based in Wageningen (the same cluster as HRB) that provides molecular breeding, trait discovery, and genomic services to global seed companies. It is a comparable ag-biotech services peer with overlapping customer base and technology scope.
  • Bayer Crop Science: Bayer Crop Science operates one of the largest in-house agricultural biotech pipelines, including CRISPR-based trait development, as part of its broader seeds-and-traits portfolio. It competes with HRB by integrating similar technologies into a much larger commercial platform.
  • Corteva Agriscience: Corteva is a major agricultural input company with significant internal gene-editing capabilities (including its own CRISPR program with Broad Institute license). It is a broad incumbent that competes for the same seed-company customer wallet as HRB, but at vastly larger scale.
  • Syngenta Group: Syngenta is a global agrochemical and seed company with active gene-editing and trait-discovery programs. It is a broad incumbent competitor that could partner with or compete against HRB depending on its internal capability roadmap.

Emerging players

  • Caribou Biosciences: Caribou Biosciences is a CRISPR platform company with applications spanning human therapeutics and agricultural biology. It is an emerging player with partial overlap — its underlying CRISPR technology platforms are conceptually adjacent to HRB's BioMaas, though its primary commercial focus is biomedical.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights7 records

Customer concentration

Hudson River Biotechnology social profiles

Digital presence

Hudson River Biotechnology financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Hudson River Biotechnology leadership team

Management profile

Number of profiles

Profiles2 records

Hudson River Biotechnology funding detail

Funding detail

Funding overview

Funding rounds3 records

Investors3 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Hudson River Biotechnology M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Hudson River Biotechnology

What does Hudson River Biotechnology do?

Hudson River Biotechnology provides a DNA-free CRISPR-based genome editing service for crop plants through its proprietary BioMaas platform. The platform uses protoplast-based delivery to edit plant genomes without introducing foreign DNA, supporting multi-trait targeting and scalable automation. Products are delivered to crop producers and agricultural biotechnology partners in a 12-18 month timeline.

Is Hudson River Biotechnology a public or private company?

Hudson River Biotechnology is a private company. It is classified as venture growth investor backed and is currently operating.

When was Hudson River Biotechnology founded?

Hudson River Biotechnology was founded in 2021. It employs 11 to 50 people.

Where is Hudson River Biotechnology based?

Hudson River Biotechnology is headquartered in Wageningen, Netherlands, in the Europe region.

How does Hudson River Biotechnology make money?

Two revenue lines are on record. CRISPR Genome Editing Services are the primary driver. The others are agrochemical Development.

Who are Hudson River Biotechnology's main competitors?

Direct peers on record are Pairwise, Tropic Biosciences, Cibus, Inari Agriculture and Benson Hill. Broad incumbents are KeyGene, Bayer Crop Science, Corteva Agriscience and Syngenta Group. Caribou Biosciences is listed as an emerging player.

Does Hudson River Biotechnology have an API?

No public API is recorded for Hudson River Biotechnology.

What industry is Hudson River Biotechnology in?

Hudson River Biotechnology's product category is Plant Biotechnology / Agricultural Genome Editing Services. Its primary akta.pro industry code is AFAGAIAG, Biotechnology & Gene-Edited Trait Development.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
AgFunderNewsExclusive: Plantik and Hudson River Biotechnology team up to de-risk heat-tolerant strawberriesPlantik Biosciences and Hudson River Biotechnology are partnering to develop heat tolerance in strawberries, combining Plantik's validated heat-tolerant targets with Hudson River's transgene-free genome editing. Validation trials are underway, and the companies plan to extend the approach to other crops.Agnavigator‘Bring us the trait you haven’t solved’: Biographica and Hudson River issue open call to breedersBiographica and Hudson River Biotechnology are partnering to tackle crop traits that conventional breeding has failed to solve, starting with tomato. They are inviting breeders to submit trait challenges at a London summit, with projects selected from those submissions. The partnership aims to bridge trait discovery and genome editing into a single route to edited plants.HudsonriverbiotechnologyHudson River BiotechnologyHudson River Biotechnology has secured a new investment round from Oost NL and Eurogenetic to scale up its commercial operations and further develop CRISPR-based crop breeding technologies. This funding follows the European Parliament's decision to relax regulations on new genetic techniques like CRISPR, distinguishing them from banned transgenic GMOs. The capital will support the company in accelerating the development of resilient crops with improved yield and nutritional value.AgFunderNewsEXCLUSIVE: Crop CRISPR startup Hudson River Biotechnology raises $5.9m Series A fundingHudson River Biotechnology raised €5 million in Series A funding led by Bridford Group, with half non-dilutive. The Dutch startup will use the capital to develop its nanotech delivery platform for agrochemicals and scale its crop-breeding business.AgFunderNewsEXCLUSIVE: Crop CRISPR startup Hudson River Biotechnology raises $5.9m Series A fundingDutch ag biotech startup Hudson River Biotechnology has raised €5 million ($5.94 million) in Series A funding, led by the UK-based Bridford Group. The company plans to use the capital to expand its CRISPR-based crop breeding business and develop a new nanotech delivery platform for agrochemicals.